Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells

about

Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.Activity-based probes for the multicatalytic proteasome.Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib

P2860

Q37627001-BD146051-622E-49BF-94A6-9CFF36C32E38 Q39096761-5D7A9E8C-03FF-41E7-85F9-6173DFB915A0 Q58612405-AAED59A0-1BEB-4171-9D07-92B931A34ECE

P2860

Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells

Item

http://www.wikidata.org/entity/Q36098363

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@ast

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@en

type

Item

label

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@ast

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@en

prefLabel

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@ast

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@en

P1476

Specificity of Protein Covalen ...... tor Carfilzomib in Human Cells

@en

P2093

Daniel C Liebler

http://www.w3.org/2001/XMLSchema#string

Eric Lowe

http://www.w3.org/2001/XMLSchema#string

F Peter Guengerich

http://www.w3.org/2001/XMLSchema#string

Hansen Wong

http://www.w3.org/2001/XMLSchema#string

Juli Teague

http://www.w3.org/2001/XMLSchema#string

Simona G Codreanu

http://www.w3.org/2001/XMLSchema#string

P2860

MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis

Developing irreversible inhibitors of the protein kinase cysteinome

Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutan

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

Cyp27c1 Red-Shifts the Spectral Sensitivity of Photoreceptors by Converting Vitamin A1 into A2.

Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

ProteoWizard: open source software for rapid proteomics tools development.

A phase 1 dose escalation study of the safety and pharmacokinetics of the novel proteasome inhibitor carfilzomib (PR-171) in patients with hematologic malignancies.

Carfilzomib: a novel second-generation proteasome inhibitor

P304

3233-3242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M116.059709

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sandeep Goyal

Matthew E Albertolle

Joel D Federspiel

P577

2016-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27503896

http://www.w3.org/2001/XMLSchema#string

P932

5054346

http://www.w3.org/2001/XMLSchema#string

Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells

about

P2860

P2860

Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932